Raploc

Medicinal product

(Invented) name

Raploc

Active substance (s)

Landiololio hidrochloridas

Strength

600 mg

Pharmaceutical form

milteliai infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C07AB14, Landiolol

Marketing authorisation holder

Amomed Pharma GmbH, Austrija

Date of authorisation

2017-02-13

Date of renewal

Documents

4047_2_3 Raploc 300_600 milt inf PCS 180115.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

NL/H/3368/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Viename flakone yra	1 vnt.
Landiololio hidrochloridas	600 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
60986	75295	1075295	flakonas	N1		Receptinis	LT/1/17/4047/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2018-06-05	Išregistruotas
2017-02-13	Registruotas